PETACH TIKVA, Israel - Nanox.AI, a subsidiary of medical imaging technology company Nanox (NASDAQ: NNOX), has reported that its artificial intelligence solution, HealthVCF, has significantly increased the detection of vertebral compression fractures (VCFs) during routine CT scans. These fractures are a key indicator of osteoporosis risk.
The early findings from the AI-enabled Detection of OsteoPorosis for Treatment (ADOPT) study suggest that the use of HealthVCF has led to the identification of up to six times more patients with VCFs than the UK National Health Service's national average.
The ADOPT study, which will continue through February 2025, has already flagged over 2,400 patients with previously undetected VCFs for follow-up assessments. This increase in patient identification has been observed at ADOPT sites, including the University Hospital Southampton NHS Foundation Trust. The HealthVCF bone solution is credited with improving identification rates and subsequent inclusion in the Fracture Liaison Service (FLS) database for follow-up care.
Osteoporosis is a progressive bone disease that typically affects adults over 50, leading to weakened bones and fractures. VCFs are often overlooked, despite being a strong risk factor for the disease. The World Congress of Osteoporosis estimates that approximately 66% of vertebral compression fractures in osteoporosis cases are undetected or unreported.
Professor Kassim Javaid of the University of Oxford, who is leading the research, highlighted the potential of AI in identifying VCFs, which can lead to early osteoporosis diagnosis and treatment, thereby reducing fracture risk and healthcare costs.
The study's findings underscore the importance of early detection and intervention in osteoporosis care. With modern treatments available, early intervention can improve bone strength and reduce the risk of fractures. The ADOPT study aims to demonstrate the real-world impact and potential cost savings of integrating AI technology into healthcare systems.
Nanox.AI has also developed an updated version of HealthVCF, named HealthOST, which can highlight low bone mineral density and measure the severity of detected VCFs. HealthOST received FDA 510(K) clearance in April 2022.
The information in this article is based on a press release statement from Nano-X Imaging LTD.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.